MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE:MDT) announced today the first U.S. patient implant in a feasibility study to evaluate the use of the Medtronic Melody™ Transcatheter Pulmonary Valve and Ensemble™ Transcatheter Delivery System to treat patients requiring congenital pulmonary heart valve replacement.
